Lupin surges on inking agreement with DKSH to market five Biosimilar candidates in Philippines

07 Sep 2022 Evaluate

Lupin is currently trading at Rs. 663.80, up by 10.90 points or 1.67% from its previous closing of Rs. 652.90 on the BSE.

The scrip opened at Rs. 647.05 and has touched a high and low of Rs. 664.00 and Rs. 647.05 respectively. So far 34317 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 995.00 on 15-Sep-2021 and a 52 week low of Rs. 583.05 on 25-May-2022.

Last one week high and low of the scrip stood at Rs. 668.80 and Rs. 647.05 respectively. The current market cap of the company is Rs. 29983.23 crore.

The promoters holding in the company stood at 47.10%, while Institutions and Non-Institutions held 41.45% and 11.45% respectively.

Lupin and DKSH have inked an exclusive licensing and supply agreement to commercialize five of Alvotech’s proposed biosimilars in the Philippines. The biosimilars planned under this agreement include biosimilar Prolia (denosumab 60mg/ml), Xgeva (denosumab 70 mg/ml), Simponi (golimumab), and Eylea (aflibercept) as well as two undisclosed proposed biosimilars for immunology and oncology.

According to the agreement, Lupin’s subsidiary in Philippines, Multicare Pharmaceuticals, will file for marketing approval and be responsible for distribution and commercialization of the biosimilars once approved.

These reference products are used to treat disorders relating to bone disease, oncology, immunology and ophthalmology. This agreement enhances Multicare’s oncology, rheumatology, gastroenterology and ophthalmology, portfolio, which currently consists of three biosimilar candidates and over 50 generic medicines.

Alvotech is a biotech company focused solely on the development and manufacture of biosimilar medicines for patients worldwide.

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.

Lupin Share Price

2133.50 -3.65 (-0.17%)
27-Jan-2026 14:49 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1634.40
Dr. Reddys Lab 1237.10
Cipla 1310.80
Zydus Lifesciences 892.40
Lupin 2133.50
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×